0001181431-13-041164.txt : 20130723 0001181431-13-041164.hdr.sgml : 20130723 20130723191210 ACCESSION NUMBER: 0001181431-13-041164 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20130723 FILED AS OF DATE: 20130723 DATE AS OF CHANGE: 20130723 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: OncoMed Pharmaceuticals Inc CENTRAL INDEX KEY: 0001302573 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 383572512 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-995-8200 MAIL ADDRESS: STREET 1: 800 CHESAPEAKE DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: VERTICAL GROUP LP CENTRAL INDEX KEY: 0001180179 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35993 FILM NUMBER: 13982250 BUSINESS ADDRESS: STREET 1: 25 DEFOREST AVE CITY: SUMMIT STATE: NJ ZIP: 07901 BUSINESS PHONE: 9082773737 MAIL ADDRESS: STREET 1: 25 DEFOREST AVE CITY: SUMMIT STATE: NJ ZIP: 07901 4 1 rrd386053.xml X0306 4 2013-07-23 1 0001302573 OncoMed Pharmaceuticals Inc OMED 0001180179 VERTICAL GROUP LP 25 DEFOREST AVE SUMMIT NJ 07901 0 0 1 0 Common Stock 2013-07-23 4 C 0 473122 A 473122 I See Footnote Common Stock 2013-07-23 4 C 0 547205 A 1020327 I See Footnote Common Stock 2013-07-23 4 C 0 666661 A 1686988 I See Footnote Common Stock 2013-07-23 4 C 0 237403 A 237403 I See Footnote Common Stock 2013-07-23 4 C 0 287527 A 524930 I See Footnote Common Stock 2013-07-23 4 C 0 278764 A 803694 I See Footnote Series A Preferred Stock 2013-07-23 4 C 0 473122 D Common Stock 473122 0 I See Footnote Series A Preferred Stock 2013-07-23 4 C 0 237403 D Common Stock 237403 0 I See Footnote Series B Preferred Stock 2013-07-23 4 C 0 547205 D Common Stock 547205 0 I See Footnote Series B Preferred Stock 2013-07-23 4 C 0 287527 D Common Stock 287527 0 I See Footnote Series B-1 Preferred Stock 2013-07-23 4 C 0 666661 D Common Stock 666661 0 I See Footnote Series B-1 Preferred Stock 2013-07-23 4 C 0 278764 D Common Stock 278764 0 I See Footnote Each share of Series A, Series B and Series B-1 Preferred Stock automatically converted on a one-to-one basis into Common Stock immediately prior to the consummation of the Issuer's initial public offering on July 23, 2013. The shares are held directly by Vertical Fund I, L.P., ("VFI"), a Delaware limited partnership. The Vertical Group, L.P. ("VG LP"), a Delaware limited partnership, is the sole general partner of VFI, and The Vertical Group GP, LLC ("VG LLC"), a Delaware limited liability company, controls VG LP. VG LP and VG LLC disclaim beneficial ownership of all securities that may be deemed to be beneficially owned by VFI except to the extent of any pecuniary interest therein. This Form 4 shall not be deemed an admission that VG LP, VG LLC or any other person referred to herein is a beneficial owner of any securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. The shares are held directly by Vertical Fund II, L.P., ("VFII"), a Delaware limited partnership. The Vertical Group, L.P. ("VG LP"), a Delaware limited partnership, is the sole general partner of VFII, and The Vertical Group GP, LLC ("VG LLC"), a Delaware limited liability company, controls VG LP. VG LP and VG LLC disclaim beneficial ownership of all securities that may be deemed to be beneficially owned by VFII except to the extent of any pecuniary interest therein. This Form 4 shall not be deemed an admission that VG LP, VG LLC or any other person referred to herein is a beneficial owner of any securities for purposes of Section 16 of the Securities Exchange Act of 1934 or for any other purpose. The securities are immediately convertible. The expiration date is not relevant to the conversion of these securities. /s/ John E. Runnells, Authorized Signatory for The Vertical Group, L.P. 2013-07-23